Abstract:RNA aptamers are oligonucleotides that bind with high specificity and affinity to target ligands. In the absence of bound ligand, secondary structures of RNA aptamers are generally stable, but single-stranded and loop regions, including ligand binding sites, lack defined structures and exist as ensembles of conformations. For example, the well-characterized theophylline-binding aptamer forms a highly stable binding site when bound to theophylline, but the binding site is unstable and disordered when theophylline is absent. Experimental methods have not revealed at atomic resolution the conformations that the theophylline aptamer explores in its unbound state. Consequently, in the present study we applied 21 microseconds of molecular dynamics simulations to structurally characterize the ensemble of conformations that the aptamer adopts in the absence of theophylline. Moreover, we apply Markov state modeling to predict the kinetics of transitions between unbound conformational states. Our simulation results agree with experimental observations that the theophylline binding site is found in many distinct binding-incompetent states and show that these states lack a binding pocket that can accommodate theophylline. The binding-incompetent states interconvert with binding-competent states through structural rearrangement of the binding site on the nanosecond to microsecond timescale. Moreover, we have simulated the complete theophylline binding pathway. Our binding simulations supplement prior experimental observations of slow theophylline binding kinetics by showing that the binding site must undergo a large conformational rearrangement after the aptamer and theophylline form an initial complex, most notably, a major rearrangement of the C27 base from a buried to solvent-exposed orientation. Theophylline appears to bind by a combination of conformational selection and induced fit mechanisms. Finally, our modeling indicates that when Mg2+ ions are present the population of binding-competent aptamer states increases more than twofold. This population change, rather than direct interactions between Mg2+ and theophylline, accounts for altered theophylline binding kinetics.

Regulating Effects of Oligonucleotides on Polymorphic Theophylline Crystals

Supramolecular architecture of theophylline polymorphs, monohydrate and co-crystals with iodine: study from the energetic viewpoint

The molecular mechanisms of plasticity in crystal forms of theophylline

Cooperative structure-directing effect in the synthesis of aluminophosphate molecular sieves in ionic liquids.

Recent advances in pharmaceutical cocrystals of theophylline

Tailoring crystal shape and polymorphism using combinations of solvents and a structurally related additive

Controlling the crystal growth of DNA molecules via strategic chemical modifications

Studies On The Endogenous Compounds Targeting To Nucleic Acids

Effects of Structure Similar Additive on the Crystallization of L-Phenylalanine from Aqueous Solution

Regulation of Oligonucleotide Adsorption by a Thermo and Ph Dual-Responsive Copolymer Layer

Molecular simulations and Markov state modeling reveal the structural diversity and dynamics of a theophylline-binding RNA aptamer in its unbound state

Solvent-dependent Crystal Shape of Theophylline using Constant Chemical Potential Molecular Dynamics Simulations

Investigation on the interaction between theophylline and alkaline substances using the DAOSD approach

Development Strategies of Polymorphs and Solvates for Enhancing Powder Properties: A Case Study of Thiothiamine

Synthon polymorphs of 1 : 1 co-crystal of 5-fluorouracil and 4-hydroxybenzoic acid: their relative stability and solvent polarity dependence of grinding outcomes

Polymorph selection of pharmaceutical cocrystals via bench-top and continuous production techniques

Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth

Theoretical insights into influence of additives on sulfamethoxazole crystal growth kinetics and mechanisms

Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide)

Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability

Discriminating and understanding molecular crystal polymorphism.